Correlation Between Biotechnology Portfolio and Dreyfus Technology

Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Dreyfus Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Dreyfus Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Dreyfus Technology Growth, you can compare the effects of market volatilities on Biotechnology Portfolio and Dreyfus Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Dreyfus Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Dreyfus Technology.

Diversification Opportunities for Biotechnology Portfolio and Dreyfus Technology

0.03

Correlation Coefficient

Biotechnology Portfolio  Dreyfus Technology

Significant diversification

The 3 months correlation between Biotechnology and Dreyfus is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Dreyfus Technology Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dreyfus Technology Growth and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Dreyfus Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dreyfus Technology Growth has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Dreyfus Technology go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Dreyfus Technology

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to under-perform the Dreyfus Technology. But the mutual fund apears to be less risky and, when comparing its historical volatility, Biotechnology Portfolio Biotechnology is 1.1 times less risky than Dreyfus Technology. The mutual fund trades about -0.21 of its potential returns per unit of risk. The Dreyfus Technology Growth is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  7,880  in Dreyfus Technology Growth on October 22, 2024 and sell it today you would earn a total of  4.00  from holding Dreyfus Technology Growth or generate 0.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Portfolio Biotec  vs.  Dreyfus Technology Growth

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Dreyfus Technology Growth

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Dreyfus Technology Growth are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Dreyfus Technology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Portfolio and Dreyfus Technology

The main advantage of trading using opposite Biotechnology Portfolio and Dreyfus Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Dreyfus Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dreyfus Technology will offset losses from the drop in Dreyfus Technology's long position.

The idea behind Biotechnology Portfolio Biotechnology and Dreyfus Technology Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.